Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Discover ways to work from home for immediate income and boost your earnings. Start your journey towards financial stability today.
18,481 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
When biotech headlines hit, stocks can swing quickly. Here’s a grounded look at why stock skyrocketed today for Q32 B...
XRP remains in a tight battle between support and supply as July markets unfold. A breach of key levels could set XR...
Bitcoin climbed through the 65,000 level, signaling fresh momentum. Traders weigh whether the rally will last or fade...
Crypto social activity just fell to a multi-month low, signaling a rare lull in online chatter. Analysts say this qui...
Crypto.com secures $400 million in fresh capital led by Citadel Securities, lifting its valuation and energizing the ...
Jim Cramer's latest remarks position Broadcom as a compass for market turning points. As AI demand drives chipmakers,...
Uniswap community votes on v4 fees and Robinhood Chain expansion, potentially boosting the UNI burn as part of the UN...
A Monday surge put Archer Aviation stock in the spotlight as investors reacted to major eVTOL news. This guide breaks...
Archer Aviation takes a bold leap with Halo, a pilotless, hybrid-electric tilt-rotor aircraft developed with Anduril....
A pricing glitch in Moonwell's oracle feed sparked a wave of liquidations, leaving roughly $1.8 million in bad debt. ...
A regulatory hint sent Moderna stock just popped, but the journey from acceptance to approval matters. This guide bre...